Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (36)

2024

  1. Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe

    Pediatric Infectious Disease Journal, Vol. 43, Núm. 5, pp. E155-E159

  2. Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART

    Frontiers in Immunology, Vol. 15

2023

  1. Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile

    Pediatric Research, Vol. 94, Núm. 5, pp. 1667-1674

  2. The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmission

    PLoS ONE, Vol. 18, Núm. 2 February

  3. Treatments for multi-system inflammatory syndrome in children — discharge, fever, and second-line therapies

    European Journal of Pediatrics, Vol. 182, Núm. 1, pp. 461-466

2022

  1. Antibiotic Prescribing in Children Hospitalized With COVID-19 and Multisystem Inflammatory Syndrome in Spain: Prevalence, Trends, and Associated Factors

    Journal of the Pediatric Infectious Diseases Society, Vol. 11, Núm. 5, pp. 225-228

  2. Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children

    European journal of pediatrics, Vol. 181, Núm. 3, pp. 1105-1115

  3. Comparison of pneumonia features in children caused by SARS-CoV-2 and other viral respiratory pathogens

    Pediatric Pulmonology, Vol. 57, Núm. 10, pp. 2374-2382

  4. Dynamics of Reverse Transcription-Polymerase Chain Reaction and Serologic Test Results in Children with SARS-CoV-2 Infection

    Journal of Pediatrics, Vol. 241, pp. 126-132.e3

  5. Manifestations and clinical phenotypes are not specific enough to predict SARS-CoV-2 infection in symptomatic children

    Acta Paediatrica, International Journal of Paediatrics, Vol. 111, Núm. 10, pp. 1974-1977

  6. Oral Versus Intravenous Antibiotics for Pediatric Osteoarticular Infection: When and to Whom?

    Pediatric Infectious Disease Journal, Vol. 41, Núm. 9, pp. E351-E357

  7. Oral saliva swab reverse transcription PCR for Covid-19 in the paediatric population

    Archives of Disease in Childhood, Vol. 107, Núm. 11, pp. 1051-1058

  8. Staphylococcus aureus Community-acquired Pneumonia in Children After 13-Valent Pneumococcal Vaccination (2008-2018): Epidemiology, Clinical Characteristics and Outcomes

    The Pediatric infectious disease journal, Vol. 41, Núm. 5, pp. e235-e242

  9. Viruses and Mycoplasma pneumoniae are the main etiological agents of community-acquired pneumonia in hospitalized pediatric patients in Spain

    Pediatric pulmonology, Vol. 57, Núm. 1, pp. 253-263

2021

  1. A Bayesian Model to Predict COVID-19 Severity in Children

    Pediatric Infectious Disease Journal, Vol. 40, Núm. 8, pp. E287-E293

  2. Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old

    European Journal of Pediatrics, Vol. 180, Núm. 7, pp. 2099-2106

  3. Multi-inflammatory Syndrome in Children Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Spain

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 72, Núm. 9, pp. e397-e401

  4. Prevalence of thrombotic complications in children with SARS-CoV-2

    Archives of Disease in Childhood, Vol. 106, Núm. 11, pp. 1129-1132

  5. QuantiFERON-TB Gold Plus Assay Specificity in Children and Adolescents With Suspected Tuberculosis - A Multicenter Cross-sectional Study in Spain

    Pediatric Infectious Disease Journal, Vol. 40, Núm. 9, pp. E348-E351

  6. Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain

    JAMA Pediatrics